Could a mitral valve fix a tricuspid problem? small trial tests donor tissue swap
NCT ID NCT06196684
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a donated mitral valve can safely replace a diseased tricuspid valve in 30 patients with primary tricuspid valve disease. The goal is to see if this approach is safe and works well in the short term. Researchers will track complications like bleeding, stroke, and valve function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
mitral valve allograft (donor tissue)
What this could lead to
If successful, this could offer a new surgical option for tricuspid valve replacement using donor tissue, potentially improving outcomes.
What could go wrong
This is a very small, early-stage study with only 30 participants, so results may not apply widely. Risks include bleeding, infection, and valve dysfunction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLOGRAFTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Cardiac Surgery
Chelyabinsk, Chelyabinsk Oblast, 454076, Russia